INSM Stock Price Forecast. Should You Buy INSM?
Stock Details
INSM 92
Insmed (INSM) PT Raised to $92 at Mizuho, 'continue to favor it as our top longer-term idea'
Graig Suvannavejh·Thu Aug 15 2024
Mizuho Securities
INSM 85
Insmed price target raised to $85 from $77 at Wells Fargo
Tiago Fauth·Fri Aug 09 2024
Wells Fargo
INSM 95
Insmed price target raised to $95 from $70 at Guggenheim
Vamil Divan·Tue Jul 09 2024
Guggenheim
INSM 88
Insmed (INSM) PT Raised to $88 at Truist Securities
Nicole Germino·Mon Jul 01 2024
Truist Financial
INSM 90
Insmed (INSM) PT Raised to $90 at Barclays
Leon Wang·Tue Jun 25 2024
Barclays
INSM 75
Insmed (INSM) PT Raised to $75 at Evercore ISI
Liisa Bayko·Fri Jun 21 2024
Evercore ISI
INSM 82
Insmed (INSM) PT Raised to $82 at Mizuho
Graig Suvannavejh·Fri Jun 07 2024
Mizuho Securities
INSM 74
Insmed price target raised to $74 from $67 at Stifel
Stephen Willey·Wed Jun 05 2024
Stifel Nicolaus
INSM 77
Insmed (INSM) PT Raised to $77 at Wells Fargo
Tiago Fauth·Wed May 29 2024
Wells Fargo
INSM 70
Insmed (INSM) PT Raised to $70 at H.C. Wainwright
Andrew Fein·Wed May 29 2024
H.C. Wainwright
INSM 58
Insmed (INSM) PT Raised to $58 at UBS
Trung Huynh·Wed May 29 2024
UBS
INSM 68
Insmed (INSM) PT Raised to $68 at Truist Securities
Nicole Germino·Wed May 29 2024
Truist Financial
INSM 54
Insmed (INSM) PT Raised to $54 at Wolfe Research
Andy Chen·Wed May 29 2024
Wolfe Research
INSM 60
Insmed (INSM) PT Raised to $60 at Morgan Stanley
Jeffrey Hung·Tue May 28 2024
Morgan Stanley
INSM 74
Goldman Sachs Reiterates Buy Rating on Insmed (INSM)
Andrea Tan·Tue May 28 2024
Goldman Sachs
INSM 42
Evercore ISI Reiterates Outperform Rating on Insmed (INSM)
Liisa Bayko·Tue May 28 2024
Evercore ISI
INSM 36
Insmed (INSM) PT Raised to $36 at Mizuho
Graig Suvannavejh·Mon May 13 2024
Mizuho Securities
INSM 43
Insmed (INSM) PT Raised to $43 at Morgan Stanley
Jeffrey Hung·Thu May 09 2024
Morgan Stanley
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow